Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 26360 | 211 | 31.2 | 68% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1864 | 5519 | JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY//MANNOSE RECEPTOR//ENDO180 |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | MONOCYTE MATURATION | Author keyword | 1 | 50% | 1% | 2 |
| 2 | PEPTIDE FRACTION | Author keyword | 1 | 50% | 1% | 2 |
| 3 | TUMORCYTOTOXICITY | Author keyword | 1 | 100% | 1% | 2 |
| 4 | AGAROSE COATING | Author keyword | 1 | 50% | 0% | 1 |
| 5 | ARTOCARPUS LAKOOCHA AGGLUTININ | Author keyword | 1 | 50% | 0% | 1 |
| 6 | BAIKAL SKULLCAP EXTRACT | Author keyword | 1 | 50% | 0% | 1 |
| 7 | BY ACTIVATED MACROPHAGES | Author keyword | 1 | 50% | 0% | 1 |
| 8 | CELL IMMUNOTHERAPY | Author keyword | 1 | 50% | 0% | 1 |
| 9 | DNA AND RNA CONTENT | Author keyword | 1 | 50% | 0% | 1 |
| 10 | ENDOMETRIAL ADENOCARCINOMA CELLS | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CIRCULATING BLOOD MONOCYTES | 3 | 100% | 1% | 3 |
| 2 | HUMAN MACROPHAGE MATURATION | 1 | 50% | 1% | 2 |
| 3 | TUMORCYTOTOXIC MACROPHAGES | 1 | 100% | 1% | 2 |
| 4 | CENTRIFUGATION ELUTRIATION | 1 | 50% | 0% | 1 |
| 5 | MACROPHAGE MATURATION | 1 | 22% | 1% | 2 |
| 6 | AUTOMATED CYTOFLUOROMETRY | 0 | 33% | 0% | 1 |
| 7 | MONOCYTE MATRIX METALLOPROTEINASE | 0 | 33% | 0% | 1 |
| 8 | DNA INSITU | 0 | 25% | 0% | 1 |
| 9 | CRYOPRESERVED HUMAN MONOCYTES | 0 | 20% | 0% | 1 |
| 10 | TISSUE FACTOR TF | 0 | 17% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives | 1998 | 62 | 67 | 37% |
| Macrophages as novel cellular vehicles for gene therapy | 2003 | 17 | 46 | 22% |
| Isolation, characterization and cultivation of human monocytes and macrophages | 1998 | 5 | 20 | 60% |
| Macrophages in gene therapy: cellular delivery vehicles and in vivo targets | 2002 | 71 | 97 | 12% |
| Isolation, characterization and cultivation of human monocytes and macrophages | 2002 | 0 | 19 | 58% |
| Cancer immunotherapy: Hopes and pitfalls: A review | 1996 | 14 | 24 | 25% |
| FLOW CYTOMETRIC CHARACTERIZATION OF MACROPHAGES - FLUORESCENT SUBSTRATES AS MARKERS OF ACTIVATION AND DIFFERENTIATION | 1982 | 0 | 2 | 100% |
| The potential for monocyte-mediated immunotherapy during infection and malignancy - Part II: In vivo activation by exogenous cytokines and clinical applications | 1999 | 4 | 107 | 7% |
| The immunotherapeutic potential of the monocyte | 1998 | 1 | 102 | 7% |
| Cancer immunotherapy: Potential involvement of mediators | 1997 | 2 | 108 | 4% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | U255 RECH BIOMED CORDELIERS | 1 | 50% | 0.5% | 1 |
| 2 | UMR664 | 0 | 33% | 0.5% | 1 |
| 3 | VET MED OBSTET GYNECOL | 0 | 33% | 0.5% | 1 |
| 4 | INTERDISCIPLINARY CLIN IZKF MUENSTER | 0 | 20% | 0.5% | 1 |
| 5 | AV ZHIRMUNSKII MARINE BIOL | 0 | 14% | 0.5% | 1 |
| 6 | IMMUNOL RHEUMATOL MED | 0 | 14% | 0.5% | 1 |
| 7 | UMAB | 0 | 14% | 0.5% | 1 |
| 8 | INSERM U365 | 0 | 10% | 0.5% | 1 |
| 9 | LEADINGEDGE DRUG DISCOVERY DEV DIABET | 0 | 100% | 0.5% | 1 |
| 10 | SECT ONCOL CELLULAR PATHOLTUMOR TARGETING GRP | 0 | 100% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000239378 | MS14//CD4 MESSENGER RNA//IMMUNOL 332 N LAUDERDALE POB 318 |
| 2 | 0.0000227638 | COUNTERFLOW CENTRIFUGATION ELUTRIATION//COUNTERFLOW CENTRIFUGAL ELUTRIATION//DUTTAPHRYNUS HIMALAYANUS |
| 3 | 0.0000221371 | MTP PE//LIPOSOMAL MTP PE//L MTP PE |
| 4 | 0.0000141525 | SOLCOSERYLR//WOUND HEALING DRUGS//ACTOVEGIN |
| 5 | 0.0000131129 | VORTEX STIRRING//IMMUNOMODULATING PEPTIDE//FIBRONECTIN PEPTIDES |
| 6 | 0.0000107375 | ANAT 4120//LUNG COMPARTMENTS//PULM CRIT CARE MED SECT 111G |
| 7 | 0.0000097541 | STRUCTURAL LEVELS//A STRUCTURAL PHENOMENOLOGICAL CONCEPTION//LYMPHOMA U 937 |
| 8 | 0.0000093256 | DALTONS LYMPHOMA//FK 565//POLY PLAT |
| 9 | 0.0000085550 | VIBRIOCIDAL ANTIBODIES//ANAL CONTROLE QUALITE//FROZEN CHIPS |
| 10 | 0.0000083376 | ALPHA NAPHTHYL ACETATE ESTERASE//ANAE//RESORCINOL BIS DIPHENYLPHOSPHATE |